Anti-AFAD/ AFDN/ AF6 monoclonal antibody

Anti-AFAD/ AFDN/ AF6 antibody for FACS & in-vivo assay

Target products collectionGo to AFDN/AFDN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1977-Ab-1/ GM-Tg-hg-MP1977-Ab-2Anti-Human AFDN monoclonal antibodyHuman
GM-Tg-rg-MP1977-Ab-1/ GM-Tg-rg-MP1977-Ab-2Anti-Rat AFDN monoclonal antibodyRat
GM-Tg-mg-MP1977-Ab-1/ GM-Tg-mg-MP1977-Ab-2Anti-Mouse AFDN monoclonal antibodyMouse
GM-Tg-cynog-MP1977-Ab-1/ GM-Tg-cynog-MP1977-Ab-2Anti-Cynomolgus/ Rhesus macaque AFDN monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1977-Ab-1/ GM-Tg-felg-MP1977-Ab-2Anti-Feline AFDN monoclonal antibodyFeline
GM-Tg-cang-MP1977-Ab-1/ GM-Tg-cang-MP1977-Ab-2Anti-Canine AFDN monoclonal antibodyCanine
GM-Tg-bovg-MP1977-Ab-1/ GM-Tg-bovg-MP1977-Ab-2Anti-Bovine AFDN monoclonal antibodyBovine
GM-Tg-equg-MP1977-Ab-1/ GM-Tg-equg-MP1977-Ab-2Anti-Equine AFDN monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1977-Ab-1/ GM-Tg-hg-MP1977-Ab-2; GM-Tg-rg-MP1977-Ab-1/ GM-Tg-rg-MP1977-Ab-2;
GM-Tg-mg-MP1977-Ab-1/ GM-Tg-mg-MP1977-Ab-2; GM-Tg-cynog-MP1977-Ab-1/ GM-Tg-cynog-MP1977-Ab-2;
GM-Tg-felg-MP1977-Ab-1/ GM-Tg-felg-MP1977-Ab-2; GM-Tg-cang-MP1977-Ab-1/ GM-Tg-cang-MP1977-Ab-2;
GM-Tg-bovg-MP1977-Ab-1/ GM-Tg-bovg-MP1977-Ab-2; GM-Tg-equg-MP1977-Ab-1/ GM-Tg-equg-MP1977-Ab-2
Products NameAnti-AFDN monoclonal antibody
Formatmab
Target NameAFDN
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-AFDN benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species AFAD/ AFDN/ AF6 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1977
    Target NameAFDN
    Gene ID4301,17356,26955,693560,431695,101081386,504856,100054846
    Gene Symbol and Synonyms5033403D15Rik,Af-6,AF6,Afadin,AFDN,Gm314,I-afadin,l-afadin,MLL-AF6,MLLT4,S-afadin
    Uniprot AccessionP55196,O35889
    Uniprot Entry NameAFAD_HUMAN,AFAD_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000130396
    Target ClassificationTumor-associated antigen (TAA)

    The target: AFDN, gene name: AFDN, also named as AF6, MLL-AF6, MLLT4, l-afadin. This gene encodes a multi-domain protein involved in signaling and organization of cell junctions during embryogenesis. It has also been identified as the fusion partner of acute lymphoblastic leukemia (ALL-1) gene, involved in acute myeloid leukemias with t(6;11)(q27;q23) translocation. Alternatively spliced transcript variants encoding different isoforms have been described for this gene, however, not all have been fully characterized.[provided by RefSeq, May 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.